| Dasatinib studied in …STUDIED_INderived200 of 273show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · 273 trials list this drug (45 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Lymphoma,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06124157Phase 2 · recruiting A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) · 273 trials list this drug (45 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02389309Phase 1 · active not recruiting Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors · 273 trials list this drug (45 active) | — | — | Malignant Solid Neoplasm,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07269470Phase 2 · recruiting Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007873Phase 2 · active not recruiting ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase · 273 trials list this drug (45 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03516279Phase 2 · active not recruiting Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease · 273 trials list this drug (45 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689440Phase 2 · active not recruiting Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia · 273 trials list this drug (45 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01660971Phase 1 · active not recruiting Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery · 273 trials list this drug (45 active) | — | — | Pancreatic Carcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02559778Phase 2 · recruiting Pediatric Precision Laboratory Advanced Neuroblastoma Therapy · 273 trials list this drug (45 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07804901Phase 2 · not yet recruiting Asciminib Frontline Risk Adapted · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445509Phase 1 · completed Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors · 273 trials list this drug (45 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04530565Phase 3 · active not recruiting Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults · 273 trials list this drug (45 active) | — | — | B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04971226Phase 3 · active not recruiting A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP · 273 trials list this drug (45 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070499Phase 2 · active not recruiting Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00792948Phase 2 · active not recruiting Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia,Adult Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940297Phase 2 · recruiting Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma · 273 trials list this drug (45 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04838041Phase 2 · recruiting Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation · 273 trials list this drug (45 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03906292Phase 2 · active not recruiting Frontline Asciminib Combination in Chronic Phase CML · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06390319Phase 2 · recruiting Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL) · 273 trials list this drug (45 active) | — | — | T Acute Lymphoblastic Leukemia,T-Cell Non-Hodgkin Lymphoma,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02143414Phase 2 · active not recruiting Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03020030Phase 3 · active not recruiting Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents · 273 trials list this drug (45 active) | — | — | Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06533748Phase 2 · recruiting Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01916785Phase 2 · completed OPTIM DASATINIB (Optimized Tyrosine Kinase Inhibitors Monotherapy) · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02494882Phase 1 · active not recruiting Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04877522Phase 4 · recruiting Asciminib Roll-over Study · 273 trials list this drug (45 active) | — | — | Leukemia,Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07025226early Phase 1 · recruiting Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease · 273 trials list this drug (45 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03117751Phase 2/Phase 3 · active not recruiting Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04747912Phase 2 · recruiting Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO) · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883049Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations · 273 trials list this drug (45 active) | — | — | Central Nervous System Leukemia,Testicular Leukemia,B Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04872790Phase 1 · active not recruiting Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia · 273 trials list this drug (45 active) | — | — | B Acute Lymphoblastic Leukemia,Mixed Phenotype Acute Leukemia,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04925648Phase 2 · completed Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction · 273 trials list this drug (45 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04329325Phase 2 · active not recruiting Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03297606Phase 2 · recruiting Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) · 273 trials list this drug (45 active) | — | — | Solid Neoplasm,Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06645886Phase 1 · active not recruiting A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies · 273 trials list this drug (45 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07493408Phase 2 · not yet recruiting Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML · 273 trials list this drug (45 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06055621Phase 2 · recruiting Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE · 273 trials list this drug (45 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02523976Phase 2 · completed Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00364286Phase 2 · completed Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825) · 273 trials list this drug (45 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00254423Phase 2 · completed Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia · 273 trials list this drug (45 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00255346Phase 2 · completed Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) · 273 trials list this drug (45 active) | — | — | Leukemia,Mastocytosis,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03654768Phase 2 · active not recruiting Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03595917Phase 1 · recruiting ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML · 273 trials list this drug (45 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198843Phase 1/Phase 2 · terminated Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body · 273 trials list this drug (45 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05993949Phase 1 · active not recruiting Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05192889Phase 1/Phase 2 · active not recruiting Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05751044Phase 1/Phase 2 · recruiting HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00777036Phase 2 · completed A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855810Phase 2/Phase 3 · recruiting Newly-diagnosed Pediatric T-cell ALL Protocol · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01990196Phase 2 · active not recruiting Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer · 273 trials list this drug (45 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02420717Phase 2 · terminated Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | B Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, BCR-ABL1-Like | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01751425Phase 1 · terminated Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03560908Phase 1 · withdrawn Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation · 273 trials list this drug (45 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05432518early Phase 1 · recruiting Pilot Trial for Treatment of Recurrent Glioblastoma · 273 trials list this drug (45 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03844360Phase 4 · recruiting Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease · 273 trials list this drug (45 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01804985Phase 2 · completed De- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390793Phase 2 · completed Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia. · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05944783Phase 4 · not yet recruiting Bioequivalence Studies of Dasatinib 100 Mg · 273 trials list this drug (45 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254864Phase 2 · completed Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies · 273 trials list this drug (45 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164069Phase 1 · completed Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab · 273 trials list this drug (45 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04147533Phase 2 · active not recruiting Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02326311Phase 3 · completed Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ≥60 Years in Deep Molecular Response · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01471106Phase 2 · completed Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer · 273 trials list this drug (45 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06355037Phase 2 · unknown Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer · 273 trials list this drug (45 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02954523Phase 1/Phase 2 · terminated Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations · 273 trials list this drug (45 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04580121Phase 1 · completed A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420. · 273 trials list this drug (45 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06336395Phase 2 · recruiting Ma-Spore ALL 2020 Study · 273 trials list this drug (45 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04115059Phase 1 · terminated Dasatinib In Waldenström Macroglobulinemia · 273 trials list this drug (45 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02081378Phase 1 · completed A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL · 273 trials list this drug (45 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 273 trials list this drug (45 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02013648Phase 3 · completed Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™) · 273 trials list this drug (45 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04845035Phase 2 · withdrawn Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01514864Phase 2 · terminated Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation · 273 trials list this drug (45 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03193281Phase 2 · unknown KISS Study: Kinase Inhibition With Sprycel Start up · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286528completed Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00550615Phase 1/Phase 2 · completed Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma · 273 trials list this drug (45 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03625388Phase 2 · completed Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059265Phase 2 · terminated Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer · 273 trials list this drug (45 active) | — | — | Primary Peritoneal Carcinoma,Ovarian Carcinoma,Ovarian Clear Cell Cystadenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00788125Phase 1/Phase 2 · terminated Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors · 273 trials list this drug (45 active) | — | — | Childhood Germ Cell Tumor,Childhood Solid Neoplasm,Extragonadal Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00700882Phase 2 · completed Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery · 273 trials list this drug (45 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01593254Phase 2 · completed Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib · 273 trials list this drug (45 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01744652Phase 1 · completed Dasatinib and Crizotinib in Advanced Cancer · 273 trials list this drug (45 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890784Phase 3 · completed Dasatinib Holiday for Improved Tolerability · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00529763Phase 2 · completed Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02297139Phase 2 · completed Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib · 273 trials list this drug (45 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01256398Phase 2 · completed Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01306942Phase 1/Phase 2 · completed Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients · 273 trials list this drug (45 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02269267Phase 2 · completed The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01238211Phase 2 · completed Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05725200Phase 2 · recruiting Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer · 273 trials list this drug (45 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03885830completed Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01015222Phase 1 · completed Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies · 273 trials list this drug (45 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05559008Phase 1/Phase 2 · unknown A Umbrella Study in R/R PTCL Guided by Molecular Subtypes · 273 trials list this drug (45 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01850004Phase 2 · completed Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response · 273 trials list this drug (45 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00652574Phase 1 · completed Dasatinib in Resectable Malignant Pleural Mesothelioma · 273 trials list this drug (45 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03352427Phase 2 · terminated Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations · 273 trials list this drug (45 active) | — | — | Glioma,Brain Stem Neoplasm,High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03173612NA · unknown The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04155411Phase 4 · unknown Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04933526Phase 4 · unknown The Efficacy and Safety of Switching to Flumatinib Versus Dasatinib After Imatinib-related Low-grade Adverse Events in CML-CP Patients · 273 trials list this drug (45 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03023046Phase 2 · completed Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03564470Phase 2/Phase 3 · unknown Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL · 273 trials list this drug (45 active) | — | — | Leukemia,Acute Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02720185Phase 2 · terminated Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR · 273 trials list this drug (45 active) | — | — | Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02043587Phase 2 · terminated Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia,Adult Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05042531NA · unknown Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03041701Phase 1/Phase 2 · terminated Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma · 273 trials list this drug (45 active) | — | — | Rhabdomyosarcoma,Alveolar Rhabdomyosarcoma,Embryonal Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01876953Phase 1/Phase 2 · terminated Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Secondary Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia,Acute Myeloid Leukemia with del(5q)+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04835584Phase 1/Phase 2 · unknown KRT-232 and TKI Study in Chronic Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01310010Phase 2 · completed Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00566618Phase 1/Phase 2 · completed Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis · 273 trials list this drug (45 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01826838Phase 1 · withdrawn Study of Dasatinib, Androgen Deprivation Therapy and Radiation · 273 trials list this drug (45 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01724879Phase 2 · completed Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL) · 273 trials list this drug (45 active) | — | — | B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01460160Phase 2 · completed Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01620216Phase 2 · terminated Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024357NA · unknown A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia,Adult Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02596828Phase 2 · completed Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma · 273 trials list this drug (45 active) | — | — | Pineoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04925141Phase 4 · completed A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP) · 273 trials list this drug (45 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01636908NA · completed Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies. · 273 trials list this drug (45 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01441882Phase 2 · completed Dasatinib in Treating Patients With Chronic Lymphocytic Leukemia · 273 trials list this drug (45 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02750514Phase 2 · terminated An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer · 273 trials list this drug (45 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00306202Phase 1 · completed Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01652976Phase 2 · completed Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma · 273 trials list this drug (45 active) | — | — | Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01643603Phase 1 · terminated Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies · 273 trials list this drug (45 active) | — | — | Hodgkin Lymphoma,Lymphoid Leukemia,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01498445Phase 1/Phase 2 · terminated An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04578847Phase 2 · unknown A Study of REduction And DIscontinuation Treatment of TKI (Imatinib, Nilotinib, Dasatinib and Bosutinib) · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01467986Phase 2 · completed Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma · 273 trials list this drug (45 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00780676Phase 2 · terminated Personalized Treatment Selection for Metastatic Breast Cancer · 273 trials list this drug (45 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03515200Phase 1 · terminated Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00717704Phase 1 · completed Solid Tumors Using Ixabepilone and Dasatinib · 273 trials list this drug (45 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00064233Phase 1 · completed BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02428855Phase 2 · completed Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma · 273 trials list this drug (45 active) | — | — | Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04439305Phase 2 · withdrawn Testing Dasatinib as a Potential Targeted Treatment in Cancers With DDR2 Genetic Changes (MATCH-Subprotocol X) · 273 trials list this drug (45 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Lymphoma,Malignant Solid Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02923986Phase 1/Phase 2 · withdrawn Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have Failed TKI, Ph+ AML, Ph+ MDS · 273 trials list this drug (45 active) | — | — | Myelodysplastic Syndrome,Myeloid Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02779283Phase 1 · completed Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720109Phase 2/Phase 3 · completed Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638428Phase 2 · unknown Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy · 273 trials list this drug (45 active) | — | — | Childhood Solid Neoplasm,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02011945Phase 1 · completed A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01609816Phase 1 · terminated Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma · 273 trials list this drug (45 active) | — | — | Hodgkin Lymphoma,Multiple Myeloma,Non-Hodgkin Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00869401Phase 1/Phase 2 · completed Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 273 trials list this drug (45 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02819804Phase 1 · terminated Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Adult Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01872442Phase 2 · completed Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic Phase · 273 trials list this drug (45 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00036738Phase 2 · completed Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib · 273 trials list this drug (45 active) | — | — | Adult Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02268370Phase 2 · unknown Treatment-free Remission Accomplished With Dasatinib in Patients With CML · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00892177Phase 2 · completed Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme · 273 trials list this drug (45 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00501410Phase 1 · completed FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer · 273 trials list this drug (45 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01876212Phase 2 · completed Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma · 273 trials list this drug (45 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423735Phase 2 · completed Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma · 273 trials list this drug (45 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00568750Phase 2 · completed Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors · 273 trials list this drug (45 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01644773Phase 1 · completed Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG) · 273 trials list this drug (45 active) | — | — | Diffuse Intrinsic Pontine Glioma,High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00459342Phase 2 · completed Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer · 273 trials list this drug (45 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00570700Phase 2 · completed Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer · 273 trials list this drug (45 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03079505Phase 3 · terminated Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00882583Phase 1 · terminated A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC · 273 trials list this drug (45 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00464620Phase 2 · completed Trial of Dasatinib in Advanced Sarcomas · 273 trials list this drug (45 active) | — | — | Chordoma,Chondrosarcoma,Ewing Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00895960Phase 1 · terminated Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma · 273 trials list this drug (45 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02709083Phase 2 · terminated Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Leukemia,Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03414450Phase 1 · withdrawn Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies · 273 trials list this drug (45 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00918463Phase 2 · terminated A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) · 273 trials list this drug (45 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01260688Phase 2 · completed Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With Docetaxel · 273 trials list this drug (45 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02233049Phase 2 · unknown Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication · 273 trials list this drug (45 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03573596Phase 2 · unknown Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI Treatment · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01460693Phase 3 · completed Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia · 273 trials list this drug (45 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00859937Phase 2 · completed Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors · 273 trials list this drug (45 active) | — | — | Malignant Salivary Gland Neoplasm,Malignant Major Salivary Gland Neoplasm,Salivary Gland Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00459108Phase 2 · terminated Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery · 273 trials list this drug (45 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02680951Phase 1 · withdrawn Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01440998Phase 1 · completed Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer · 273 trials list this drug (45 active) | — | — | Endometrioid Adenocarcinoma,Endometrial Adenocarcinoma,Endometrial Mucinous Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02744768Phase 2 · unknown D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00860158Phase 2 · terminated Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer · 273 trials list this drug (45 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02815059Phase 1 · withdrawn Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01234935Phase 2 · completed Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery · 273 trials list this drug (45 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Neoplasm,Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01488318Phase 2 · terminated Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma · 273 trials list this drug (45 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00438854Phase 2 · completed Dasatinib in Relapsed Chronic Lymphocytic Leukemia · 273 trials list this drug (45 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00852566Phase 2 · completed Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02389972completed Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02546791completed Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03216070Phase 4 · unknown Low-dose Dasatinib as First-line Treatment for Chronic Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01685125Phase 2 · unknown Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer · 273 trials list this drug (45 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00410813Phase 2 · completed S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone · 273 trials list this drug (45 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00538980Phase 2 · terminated Dasatinib in Polycythemia Vera · 273 trials list this drug (45 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01173679Phase 2 · terminated Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL · 273 trials list this drug (45 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00662636Phase 1 · completed Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery · 273 trials list this drug (45 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01357655Phase 2 · terminated Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923) · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00560352Phase 1 · terminated Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma · 273 trials list this drug (45 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00481247Phase 3 · completed A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01643278Phase 1 · completed Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic · 273 trials list this drug (45 active) | — | — | Gastrointestinal Stromal Tumor,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00391989Phase 2 · completed Treatment of Adult Ph+ LAL With BMS-354825 · 273 trials list this drug (45 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02015728NA · unknown Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors · 273 trials list this drug (45 active) | — | — | Childhood Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01660906Phase 4 · completed Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib · 273 trials list this drug (45 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00744497Phase 3 · completed Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer · 273 trials list this drug (45 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01092728Phase 2 · terminated Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma · 273 trials list this drug (45 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02888990Phase 2 · completed Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic Leukemia · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00123474Phase 3 · completed Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML · 273 trials list this drug (45 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00509041Phase 2 · completed Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma · 273 trials list this drug (45 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00787267Phase 2 · terminated Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC · 273 trials list this drug (45 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00826449Phase 1/Phase 2 · completed Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) · 273 trials list this drug (45 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01218477Phase 1/Phase 2 · completed Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML) · 273 trials list this drug (45 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00696072Phase 2 · completed Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic · 273 trials list this drug (45 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00754325Phase 2 · completed Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor · 273 trials list this drug (45 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02776878NA · unknown A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST · 273 trials list this drug (45 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01482728early Phase 1 · completed Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer · 273 trials list this drug (45 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00671788Phase 2 · completed A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma · 273 trials list this drug (45 active) | — | — | Primary Peritoneal Carcinoma,Ovarian Carcinoma,Fallopian Tube Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02733445completed Metabolic Outcomes in Patients Receiving Tyrosine Kinase Inhibitor (TKI) Therapy With Dasatinib or Nilotinib · 273 trials list this drug (45 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |